Rationalizing Anti-cancer Drug Responses Using Proteomics and Machine Learning: Towards Next Generation Precision Medicine
Originally recorded July 23, 2021
Pedro R. Cutillas, PhD
Professor of Cell Signalling and Proteomics
Barts Cancer Institute
Introduction by
Tommaso Cupido, PhD
Department of Chemical Biology & Therapeutics
St. Jude Children's Research Hospital